首页 > 期刊列表> Alzheimer''s and Dementia: Translational Research and Clinical Interventions

Alzheimer''s and Dementia: Translational Research and Clinical Interventions

浏览量1881
分享 分享
微信好友 朋友圈 QQ好友 复制链接
订阅订阅 查看最新文献查看最新文献
WOS期刊分区 历年影响因子 历年发表 同类期刊
Alzheimer''s and Dementia: Translational Research and Clinical Interventions
期刊缩写:
Alzheimers Dement (N Y) 反馈 反馈
影响因子:
期刊影响因子(Impact factor,IF) 即某刊平均每篇论文的被引用数,是表征期刊影响大小的一项定量指标,它实际上是某刊在某年被全部源刊物引证该刊前两年发表论文的次数,与该刊前两年所发表的全部源论文数之比。
4.9 反馈 反馈
ISSN:
ISSN是由8个数字组成的编码,旨在识别各种报纸、专业杂志、画报、期刊,无论其性质或载体版本(纸版及电子版)。
print: 2352-8737
研究领域:
Medicine-Psychiatry and Mental Health
自引率:
2.10%
Gold OA文章占比:
Gold OA文章占比是指一个总体中金色OA文章数量占总体文章数量的比重。OA期刊的文章主要通过金色通道(Gold road,也称为Gold OA,即期刊官网)和绿色通道(Green road,或Green OA)实现开放获取。金色通道是开放获取期刊通过自己的官网来实现的,而绿色通道是通过把文章自存档于机构知识库(Institutional Repositories,比如哈佛大学学术库DASH)或学科知识库中来实现。
66.43%
原创研究文献占比:
92.80%
SCI收录类型:
Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊主页:
期刊介绍英文:
Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.
CiteScore:
引用分数(英语:CiteScore,CS)是一种用来反映学术期刊最近发表文章“年平均被引用次数”的衡量指标。该指标由Elsevier于 2016 年 12 月推出,以替代常用的JCR影响因子(由Clarivate计算)。 CiteScore是Scopus中系列期刊指标的一部分,包括 SNIP(源文档标准化影响),SJR (SClmago杂志排名),引用文档计数以及引用百分比。
CiteScoreSJRSNIPCiteScore排名
10.11.7171.304
学科
排名
百分位
大类:Medicine
小类:Psychiatry and Mental Health
48 / 567
91%
大类:Medicine
小类:Neurology (clinical)
40 / 400
90%

发文信息

WOS期刊分区

WoS-JCR分区:SCIE、SSCI收录期刊主要按影响因子高低被分为四个区(Quartile),分别是Q1区,Q2区,Q3区,Q4区,各占25%。Q1区是影响因子最靠前25%的期刊,Q4区是靠后的25%的期刊。
学科分类
Q1CLINICAL NEUROLOGY
Q1NEUROSCIENCES

历年影响因子

2022年2023年
4.80004.9000

历年发表

年文章数是指每年6月SCI发布的IF数据中所提供的上一年全年发文数量。如2018年7月-2019年6月,显示的是2017年的发文数.对极少数热门期刊,我们会在1月份更新为最新一年的发文数。
2014年2015年2016年2017年2018年2019年2020年2021年2022年
025457184100117117134
出版语言:
English
出版国家(地区):
United States
审稿时长:
10 weeks
论文处理费:
$2000
出版商:
Wiley-Blackwell
PubMed链接:

同类期刊

Arthritis Research & Therapy
Arthritis Research & Therapy
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics
Business Ethics-A European Review
Business Ethics-A European Review
Animal microbiome
Animal microbiome
Computers in human behavior reports
Computers in human behavior reports
Journal of Membrane Science Letters
Journal of Membrane Science Letters

Alzheimer''s and Dementia: Translational Research and Clinical Interventions - 最新文献

查看全部

Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurology

Pub Date : 2024-09-18 DOI: 10.1002/trc2.12500 Gregory A. Jicha, Erin L. Abner, Elif P. Coskun, Mark J. Huffmyer, Thomas C. Tucker, Peter T. Nelson

Anti-epileptic drug use and subsequent degenerative dementia occurrence

Pub Date : 2024-09-10 DOI: 10.1002/trc2.70001 Naoki Ikegaya, Honoka Nakamura, Yutaro Takayama, Yohei Miyake, Takahiro Hayashi, Masaki Sonoda, Mitsuru Sato, Kensuke Tateishi, Jun Suenaga, Masao Takaishi, Yu Kitazawa, Misako Kunii, Hiroki Abe, Tomoyuki Miyazaki, Tetsuaki Arai, Manabu Iwasaki, Takayuki Abe, Tetsuya Yamamoto

Genetically proxied IL-6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study

Pub Date : 2024-08-27 DOI: 10.1002/trc2.70000 Evangelos Pavlos Myserlis, Anushree Ray, Christopher D. Anderson, Marios K. Georgakis
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1